Oncology Nursing News®

Gynecologic Cancers

New USPSTF BRCA Recommendations Still Fall Short

New USPSTF BRCA Recommendations Still Fall Short

BY BRIELLE BENYON

FDA Approves Entrectinib for Multiple Solid Tumor Indications

FDA Approves Entrectinib for Multiple Solid Tumor Indications

BY BRIELLE BENYON

What's New in Ovarian Cancer Treatment?

What's New in Ovarian Cancer Treatment?

BY CAROLINE SEYMOUR

Personalized Medicine Is the New Frontier in Ovarian Cancer

Personalized Medicine Is the New Frontier in Ovarian Cancer

BY BRIELLE BENYON

Debate: Surgery or Chemo First in Ovarian Cancer Treatment

Debate: Surgery or Chemo First in Ovarian Cancer Treatment

BY CAROLINE SEYMOUR

FDA Approves Bevacizumab Biosimilar for 5 Cancer Types

FDA Approves Bevacizumab Biosimilar for 5 Cancer Types

BY BRIELLE BENYON

FDA Grants Priority Review to Niraparib for Late-Stage Ovarian Cancer Treatment

FDA Grants Priority Review to Niraparib for Late-Stage Ovarian Cancer Treatment

BY GINA COLUMBUS

HIPEC in Ovarian Cancer: Is It for Everyone?

HIPEC in Ovarian Cancer: Is It for Everyone?

BY BRIELLE BENYON

Oral Contraceptives Decrease Risk of Ovarian Cancer Death

Oral Contraceptives Decrease Risk of Ovarian Cancer Death

BY BRIELLE BENYON

Women with Ovarian Cancer Less Likely to Alert Providers As Symptoms Worsen

Women with Ovarian Cancer Less Likely to Alert Providers As Symptoms Worsen

BY BETH FAND INCOLLINGO

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.